Atlas Trials

Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19

Clinical trial NCT05160779 · UNKNOWN

Trial details

NCT number
NCT05160779
Sponsor
Leonardo Paroche de Matos
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Sars-CoV-2 Infection
Start date
2022-01-01
Primary completion
2022-01-01
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.